ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, presenting promising breakthroughs throughout different health-related and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, extra responsible choice for therapeutic use,